Webinar Overview​

Reliability is paramount when developing cell and gene therapies. Today, the end-product costs are a major focus and will be in the future as advanced therapies mature and continue to become more widely used. The challenges and costs associated with a therapy approval can reach hundreds of thousands of dollars per dose, which makes the cell and gene therapy manufacturing process critical. Sterile connectors can help save time and money in this process. CPC discusses connector solutions for sterility, chemical compatibility, and ultra-low temperature challenges when setting up a therapeutic process for long-term success.​

Webinar Details:

• 30 Minute presentation followed by Q&A​
• Presenter: Troy Ostreng, Senior Product Manager at CPC​
• Published and recorded by GEN - Genetic Engineering & Biotechnology News​

Learn more about sterile connector solutions for Cell and Gene Therapy